Ru‐Inn Lin

827 total citations
16 papers, 649 citations indexed

About

Ru‐Inn Lin is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ru‐Inn Lin has authored 16 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Ru‐Inn Lin's work include RNA Research and Splicing (5 papers), Nuclear Structure and Function (4 papers) and RNA modifications and cancer (4 papers). Ru‐Inn Lin is often cited by papers focused on RNA Research and Splicing (5 papers), Nuclear Structure and Function (4 papers) and RNA modifications and cancer (4 papers). Ru‐Inn Lin collaborates with scholars based in Taiwan, United States and Japan. Ru‐Inn Lin's co-authors include Woan‐Yuh Tarn, Ming‐Chih Lai, Ching-Wei Tsai, Chin Li, Pin Ouyang, Michael W.Y. Chan, Shu-Fen Wu, Moon‐Sing Lee, Iawen Hsu and Min Hsu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Ru‐Inn Lin

16 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ru‐Inn Lin Taiwan 10 582 73 63 45 37 16 649
Karine Boulay Canada 8 437 0.8× 139 1.9× 61 1.0× 36 0.8× 27 0.7× 9 549
Sabine Laurent‐Chabalier France 6 563 1.0× 68 0.9× 30 0.5× 56 1.2× 40 1.1× 15 644
Luisa Robbez‐Masson United Kingdom 7 326 0.6× 37 0.5× 22 0.3× 45 1.0× 33 0.9× 7 421
Hongdong Bai United States 10 142 0.2× 114 1.6× 47 0.7× 27 0.6× 57 1.5× 20 338
Mason Lu United States 7 290 0.5× 27 0.4× 40 0.6× 66 1.5× 20 0.5× 8 425
Toshiro Hayashida Japan 8 647 1.1× 25 0.3× 14 0.2× 80 1.8× 63 1.7× 9 703
Nicolas Strauli United States 7 218 0.4× 48 0.7× 18 0.3× 47 1.0× 16 0.4× 13 334
Ingrid Stec Netherlands 7 422 0.7× 44 0.6× 27 0.4× 46 1.0× 15 0.4× 9 527
Tara M. Young United States 9 215 0.4× 44 0.6× 58 0.9× 94 2.1× 9 0.2× 10 350
Jasmine Li Australia 12 328 0.6× 86 1.2× 43 0.7× 108 2.4× 58 1.6× 17 544

Countries citing papers authored by Ru‐Inn Lin

Since Specialization
Citations

This map shows the geographic impact of Ru‐Inn Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru‐Inn Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru‐Inn Lin more than expected).

Fields of papers citing papers by Ru‐Inn Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ru‐Inn Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru‐Inn Lin. The network helps show where Ru‐Inn Lin may publish in the future.

Co-authorship network of co-authors of Ru‐Inn Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ru‐Inn Lin. A scholar is included among the top collaborators of Ru‐Inn Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ru‐Inn Lin. Ru‐Inn Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yang, Shuyi, Wenlong Huang, Mu‐Hung Tsai, et al.. (2024). Wogonin Inhibits Ovarian Cancer by Activating the AMPK‐TET2‐5hmC Axis. Molecular Carcinogenesis. 64(3). 440–449. 3 indexed citations
2.
Lin, Hon‐Yi, Michael W.Y. Chan, Shu‐Fen Wu, et al.. (2024). Olaparib enhancing radiosensitization and anti-metastatic effect of oral cancer by targeting IL-17A signal. Cancer Cell International. 24(1). 373–373. 3 indexed citations
3.
Lin, Hon‐Yi, Chen-Hsi Hsieh, Michael W.Y. Chan, et al.. (2023). IRAK2, an Immune and Radiation-Response Gene, Correlates with Advanced Disease Features but Predicts Higher Post-Irradiation Local Control in Non-Metastatic and Resected Oral Cancer Patients. International Journal of Molecular Sciences. 24(8). 6903–6903. 3 indexed citations
4.
Jou, Yeong‐Chin, Hon‐Yi Lin, Yu‐Ming Chuang, et al.. (2021). Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma. Cancer Cell International. 21(1). 226–226. 5 indexed citations
5.
Chan, Michael W.Y., Hon‐Yi Lin, Wen‐Yen Chiou, et al.. (2021). IRAK2, an IL1R/TLR Immune Mediator, Enhances Radiosensitivity via Modulating Caspase 8/3-Mediated Apoptosis in Oral Squamous Cell Carcinoma. Frontiers in Oncology. 11. 647175–647175. 9 indexed citations
6.
Lee, Moon‐Sing, Dai‐Wei Liu, Shih‐Kai Hung, et al.. (2020). Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care. Frontiers in Cardiovascular Medicine. 7. 16–16. 9 indexed citations
7.
Shinjo, Keiko, Keisuke Katsushima, Atsushi Arakawa, et al.. (2019). ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer. Cancer Science. 110(3). 1105–1116. 30 indexed citations
8.
Chuang, Yu‐Ming, Ru‐Inn Lin, Hon‐Yi Lin, et al.. (2019). c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma. Cancers. 11(10). 1457–1457. 14 indexed citations
9.
Yeh, Chia‐Ming, Pi-Che Chen, Hsiao‐Yen Hsieh, et al.. (2015). Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma. Oncotarget. 6(30). 29555–29572. 37 indexed citations
10.
Lee, Moon‐Sing, et al.. (2009). Identification of a nuclear localization signal in the polo box domain of Plk1. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1793(10). 1571–1578. 18 indexed citations
11.
Wang, Weisheng, et al.. (2009). Interaction between human papillomavirus type 5 E2 and polo‐like kinase 1. Journal of Medical Virology. 81(3). 536–544. 9 indexed citations
12.
Hsu, Iawen, et al.. (2005). Phosphorylation of Y14 Modulates Its Interaction with Proteins Involved in mRNA Metabolism and Influences Its Methylation. Journal of Biological Chemistry. 280(41). 34507–34512. 38 indexed citations
13.
Lai, Ming‐Chih, Ru‐Inn Lin, & Woan‐Yuh Tarn. (2003). Differential effects of hyperphosphorylation on splicing factor SRp55. Biochemical Journal. 371(3). 937–945. 38 indexed citations
14.
Li, Chin, Ru‐Inn Lin, Ming‐Chih Lai, Pin Ouyang, & Woan‐Yuh Tarn. (2003). Nuclear Pnn/DRS Protein Binds to Spliced mRNPs and Participates in mRNA Processing and Export via Interaction with RNPS1. Molecular and Cellular Biology. 23(20). 7363–7376. 62 indexed citations
15.
Lai, Ming‐Chih, Ru‐Inn Lin, & Woan‐Yuh Tarn. (2001). Transportin-SR2 mediates nuclear import of phosphorylated SR proteins. Proceedings of the National Academy of Sciences. 98(18). 10154–10159. 195 indexed citations
16.
Lai, Ming‐Chih, et al.. (2000). A Human Importin-β Family Protein, Transportin-SR2, Interacts with the Phosphorylated RS Domain of SR Proteins. Journal of Biological Chemistry. 275(11). 7950–7957. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026